Hims & Hers Health (HIMS) Receivables (2020 - 2026)

Hims & Hers Health has disclosed Receivables across 7 years of filings, most recently posting $149.6 million for Q1 2026.

• Receivables for Q1 2026 came in at $149.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $149.6 million (changed N/A YoY), and the FY2025 annual result was $32.1 million, up 427.03% from the prior year.
• Receivables came in at $149.6 million for Q1 2026 at Hims & Hers Health, up from $32.1 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $149.6 million in Q1 2026 to a low of $3.9 million in Q4 2022.
• The 5-year median for Receivables is $6.7 million (2023), against an average of $39.7 million.
• Across the five-year window, Receivables retreated 8.96% in 2024 and surged 427.03% in 2025, its largest moves.
• Hims & Hers Health's Receivables stood at $3.9 million in 2022, then soared by 71.79% to $6.7 million in 2023, then declined by 8.96% to $6.1 million in 2024, then soared by 427.03% to $32.1 million in 2025, then jumped by 365.4% to $149.6 million in 2026.
• The last three Receivables figures came in at $149.6 million (Q1 2026), $32.1 million (Q4 2025), and $6.1 million (Q4 2024), per Business Quant data.